HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Clean Bill Of Health For BPA In Europe As FDA Examination Continues

This article was originally published in The Rose Sheet

Executive Summary

EFSA’s conclusion differs from decisions in Canada and the U.S. banning use of the substance as an epoxy resin coating in infant formula packaging. But EFSA lowers its “tolerable daily intake” level for BPA from 50 micrograms to 4 micrograms per kilogram of body weight.

You may also be interested in...



Walmart Program Seeks Greener Beauty, Greater Supplier Transparency

Walmart aims to reduce or eliminate high-priority toxins from its beauty offering with a program announced Sept. 12. The Campaign for Safe Cosmetics celebrates the move and calls on Target to implement a similar safe-cosmetics policy in its stores.

Regulatory News In Brief

NAD finds Nitraflex “strength” claim weak; FDA nixes BPA coating in infant formula packaging; Herbs of Light in the dark on GMPs, claims; AHPA floats softer Prop 65 warnings; and U.K. aims to end unlicensed herbal sales.

Regulatory News In Brief

Blood Products Advisory Committee considers at-home HIV test; Protica QC personnel fail on supplement GMPs; FDA warns pregnancy test maker of GMP, labeling violations; FDA uncovers more tainted supplements sold online; NRDC request for BPA ban short on data.

Related Content

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

RS019789

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel